Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu et al

Antonis Fanouriakis¹, George Bertsias², Dimitrios T Boumpas³

Affiliations

¹ Department of Rheumatology, "Asklepieion" General Hospital, Athens, Greece afanour@med.uoa.gr.
² Department of Rheumatology, University of Crete School of Medicine, Iraklio, Greece.
³ Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.

PMID: 32434817
DOI: 10.1136/annrheumdis-2020-217804

Free article

Comment

Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu et al

Antonis Fanouriakis et al. Ann Rheum Dis. 2022 May.

Free article

. 2022 May;81(5):e76.

doi: 10.1136/annrheumdis-2020-217804. Epub 2020 May 20.

Authors

Antonis Fanouriakis¹, George Bertsias², Dimitrios T Boumpas³

Affiliations

¹ Department of Rheumatology, "Asklepieion" General Hospital, Athens, Greece afanour@med.uoa.gr.
² Department of Rheumatology, University of Crete School of Medicine, Iraklio, Greece.
³ Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece.

PMID: 32434817
DOI: 10.1136/annrheumdis-2020-217804

No abstract available

Keywords: hydroxychloroquine; inflammation; lupus erythematosus, systemic.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Fanouriakis A, et al. Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27. Ann Rheum Dis. 2020. PMID: 32220834
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus.
Wu CY, Tan M, Huang JY, Chiou JY, Wei JC. Wu CY, et al. Ann Rheum Dis. 2022 May;81(5):e75. doi: 10.1136/annrheumdis-2020-217728. Epub 2020 May 20. Ann Rheum Dis. 2022. PMID: 32434824 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu et al

Affiliations

Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu et al

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical